|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
R, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cortez AJ, Tudrej P, Kujawa KA and
Lisowska KM: Advances in ovarian cancer therapy. Cancer Chemother
Pharmacol. 81:17–38. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mattick JS: The genetic signatures of
noncoding RNAs. PLoS Genet. 5(e1000459)2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kawasaki N, Miwa T, Hokari S, Sakurai T,
Ohmori K, Miyauchi K, Miyazono K and Koinuma D: Long noncoding RNA
NORAD regulates transforming growth factor-β signaling and
epithelial-to-mesenchymal transition-like phenotype. Cancer Sci.
109:2211–2220. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tripathi MK, Doxtater K, Keramatnia F,
Zacheaus C, Yallapu MM, Jaggi M and Chauhan SC: Role of lncRNAs in
ovarian cancer: Defining new biomarkers for therapeutic purposes.
Drug Discov Today. 203:1635–1643. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lu YM, Wang Y, Liu SQ, Zhou MY and Guo YR:
Profile and validation of dysregulated long noncoding RNAs and
mRNAs in ovarian cancer. Oncol Rep. 40:2964–2976. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Barber HR, Sommers SC, Synder R and Kwon
TH: Histologic and nuclear grading and stromal reactions as indices
for prognosis in ovarian cancer. Am J Obstet Gynecol. 121:795–807.
1975.PubMed/NCBI
|
|
9
|
Szafron LM, Balcerak A, Grzybowska EA,
Pienkowska-Grela B, Podgorska A, Zub R, Olbryt M, Pamula-Pilat J,
Lisowska KM, Grzybowska E, et al: The putative oncogene, CRNDE, is
a negative prognostic factor in ovarian cancer patients.
Oncotarget. 6:43897–43910. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Xu Q, Deng F, Xing Z, Wu Z, Cen B, Xu S,
Zhao Z, Nepomuceno R, Bhuiyan MI, Sun D, et al: Long non-coding RNA
C2dat1 regulates CaMKIIδ expression to promote neuronal survival
through the NF-κB signaling pathway following cerebral ischemia.
Cell Death Dis. 7(e2173)2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chen K, Liu MX, Mak CS, Yung MM, Leung TH,
Xu D, Ngu SF, Chan KK, Yang H, Ngan HY and Chan DW:
Methylation-associated silencing of miR-193a-3p promotes ovarian
cancer aggressiveness by targeting GRB7 and MAPK/ERK pathways.
Theranostics. 8:423–436. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chan JJ and Tay Y: Noncoding RNA: RNA
regulatory networks in cancer. Int J Mol Sci.
19(1310)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Mansoori Y, Tabei MB, Askari A, Izadi P,
Daraei A, Bastami M, Naghizadeh MM, Nariman-Saleh-Fam Z, Mansoori B
and Tavakkoly-Bazzaz J: Expression levels of breast cancer-related
GAS5 and LSINCT5 lncRNAs in cancer-free breast tissue: Molecular
associations with age at menarche and obesity. Breast J.
24:876–882. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang BG, Lv Z, Ding HX, Fang XX, Wen J, Xu
Q and Yuan Y: The association of lncRNA-HULC polymorphisms with
hepatocellular cancer risk and prognosis. Gene. 670:148–154.
2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Worku T, Bhattarai D, Ayers D, Wang K,
Wang C, Rehman ZU, Talpur HS and Yang L: Long non-coding RNAs: The
new horizon of gene regulation in ovarian cancer. Cell Physiol
Biochem. 44:948–966. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ding D, Li C, Zhao T, Li D, Yang L and
Zhang B: lncRNA H19/miR-29b-3p/PGRN axis promoted
epithelial-mesenchymal transition of colorectal cancer cells by
acting on Wnt signaling. Mol Cells. 41:423–435. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Qiu H, Wang X, Guo R, Liu Q, Wang Y, Yuan
Z, Li J and Shi H: HOTAIR rs920778 polymorphism is associated with
ovarian cancer susceptibility and poor prognosis in a Chinese
population. Future Oncol. 13:347–355. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zou A, Liu R and Wu X: Long non-coding RNA
MALAT1 is up-regulated in ovarian cancer tissue and promotes
SK-OV-3 cell proliferation and invasion. Neoplasma. 63:865–872.
2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Huang S, Qing C, Huang Z and Zhu Y: The
long non-coding RNA CCAT2 is up-regulated in ovarian cancer and
associated with poor prognosis. Diagn Pathol. 11(49)2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li J, Huang H, Li Y, Li L, Hou W and You
Z: Decreased expression of long non-coding RNA GAS5 promotes cell
proliferation, migration and invasion, and indicates a poor
prognosis in ovarian cancer. Oncol Rep. 36:3241–3250.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang H, Sun W, Sun M, Fu Z, Zhou C, Wang
C, Zuo D, Zhou Z, Wang G, Zhang T, et al: HER4 promotes cell
survival and chemoresistance in osteosarcoma via interaction with
NDRG1. Biochim Biophys Acta Mol Basis Dis. 1864 (5 Pt A):1839–1849.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wu XL, Lu RY, Wang LK, Wang YY, Dai YJ,
Wang CY, Yang YJ, Guo F, Xue J and Yang DD: Long noncoding RNA
HOTAIR silencing inhibits invasion and proliferation of human colon
cancer LoVo cells via regulating IGF2BP2. J Cell Biochem Oct 18,
2018 (Online ahead of print).
|
|
25
|
Chang JW, Kuo WH, Lin CM, Chen WL, Chan
SH, Chiu MF, Chang IS, Jiang SS, Tsai FY, Chen CH, et al: Wild-type
p53 upregulates an early onset breast cancer-associated gene GAS7
to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.
Oncogene. 37:4137–4150. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lu YM, Rong ML, Shang C, Wang N, Li X,
Zhao YY and Zhang SL: Suppression of HER-2 via siRNA interference
promotes apoptosis and decreases metastatic potential of SKOV3
human ovarian carcinoma cells. Oncol Rep. 29:1133–1139.
2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wei P, Li L, Zhang Z, Zhang W, Liu M and
Sheng X: A genetic variant of miR-335 binding site in the ERBB4
3'-UTR is associated with prognosis of ovary cancer. J Cell
Biochem. 119:5135–5142. 2018.PubMed/NCBI View Article : Google Scholar
|
